Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BLLN
HoldPremium GrowerBillionToOne, Inc. · Healthcare · United States · $4.4B · Avg Vol: $75M/d
COMPANY DESCRIPTION
BillionToOne, Inc. is a molecular diagnostics company leveraging its proprietary quantitative molecular counting technology to develop highly accurate non-invasive tests for prenatal conditions and early cancer detection. Its competitive advantage lies in its unique technology, which provides unprecedented resolution and sensitivity, enabling precise detection of genetic variations from small biological samples. The company is positioned to disrupt traditional genetic and oncology diagnostics with its innovative platform.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 305.1M | — | 397.4M | 455.6M | 576.3M | 37.4% |
| EPS | -2.10 | -1.05 | 0.18 | — | 0.72 | 0.16 | 0.24 | 15.7% |
| Shares | 44.7M | 44.7M | 45.8M | +2.4% | 42.6M | — | — | — |
| Debt | — | — | 108.9M | — | 143.9M | — | — | — |
| Equity | — | — | 480.1M | — | — | — | — | — |
| Op CF | — | — | 24.6M | — | 45.4M | — | — | — |
| Inv CF | — | — | -8.9M | — | — | — | — | — |
| Fin CF | — | — | 288.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BLLN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BLLN | BillionToOne, Inc.(you) | $4.4B | 61 | Hold |
| VCYT | Veracyte, Inc. | $3.5B | 80 | Strong Buy |
| ADPT | Adaptive Biotechnologies Corporation | $4.0B | 38 | Hold |
| CDNA | CareDx, Inc. | $2.6B | 75 | Buy |
| SHC | Sotera Health Company | $5.5B | 81 | Strong Buy |
| CRL | Charles River Laboratories International, Inc. | $14.0B | 63 | Hold |
| NEO | NeoGenomics, Inc. | $2.3B | 47 | Hold |
| RVTY | Revvity, Inc. | $14.4B | 64 | Hold |
| TWST | Twist Bioscience Corporation | $8.9B | 47 | Hold |
| RDNT | RadNet, Inc. | $5.9B | 34 | Sell |
Peer medians: ROE -30.7% · P/E 26.9x · Gross margin 58.1%